Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(21/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(21/week)
News
United States
(578/week)
Manufacturing
(398/week)
Energy
(304/week)
Technology
(413/week)
Environment
(238/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Leuprorelin
Jun 03, 2020
Zeulide Depot(TM) is now Covered by the Ontario Drug Benefit (ODB) Program for Patients Living with Prostate Cancer
Mar 29, 2019
Foresee Pharmaceuticals Announces Submission of NDA for FDA Approval of LMIS 50 mg
Mar 05, 2019
Enteris BioPharma Supports Endometriosis Awareness Month
Feb 21, 2019
Foresee Pharmaceuticals Announces Successful Topline Results from Phase 3 Registration Study of LMIS 25 mg in Prostate Cancer
Feb 11, 2019
Foresee Pharmaceuticals Enters Exclusive License Agreement with Accord Healthcare
Nov 26, 2018
Foresee Pharmaceuticals Announces Completion of Last Patient Visit in Registration Phase 3 Study of LMIS 25 mg (fp-001) for the Treatment of Advanced Prostate Cancer
Oct 24, 2018
Myovant Sciences Announces Completion of Enrollment in Phase 3 HERO Trial of Relugolix in Men with Advanced Prostate Cancer
Oct 05, 2018
Tolmar Pharmaceuticals Sponsors 2018 ZERO - The End of Prostate Cancer Endurance Team at the Bank of America Chicago Marathon
Jun 26, 2018
Enteris BioPharma Announces Positive Results from Expanded Phase 2a Clinical Trial of Ovarest® (oral leuprolide tablet) for Endometriosis
Mar 15, 2018
Enteris BioPharma to Present at the 25th Annual Future Leaders in the Biotech Industry Conference
Mar 01, 2018
Enteris BioPharma's "Feasibility-to-Licensing" Partner, Cara Therapeutics, Doses First Patient in Phase 1 Trial of Oral KORSUVA(TM)
Feb 13, 2018
Myovant Sciences Provides Corporate Update and Reports Financial Results for Third Fiscal Quarter Ended December 31, 2017
Nov 09, 2017
Myovant Sciences Announces Positive Top-line Results from Takeda's Phase 3 Study Evaluating the Efficacy and Safety of Relugolix for the Treatment of Pain Associated with Uterine Fibroids
Oct 02, 2017
Myovant Sciences Announces Positive Top-line Results from Takeda's Phase 3 Study Evaluating the Efficacy and Safety of Relugolix Compared with Leuprorelin for the Treatment of Uterine Fibroids
Latest News
Apr 25, 2024
Bureau Veritas: Strong Start to the Year; 2024 Outlook Confirmed
Apr 25, 2024
AprilAire® Professional-Grade Smart Thermostat Now ENERGY STAR® Certified
Apr 25, 2024
Luxury Apartments in Double Bay, Australia, Built for Durability with Penetron Technology
Apr 25, 2024
Wright Electric Announces First Steps of Electric Propulsion Testing
Apr 25, 2024
Asahi Kasei to Construct a Lithium-ion Battery Separator Plant in Canada
Apr 25, 2024
Getech Engaged by East Star Resources to Locate Porphyry Copper in Kazakhstan
Apr 25, 2024
Helix Reports First Quarter 2024 Results
Apr 25, 2024
Mativ Announces Appointment of New Chair of its Board of Directors
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events